Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Independent UK
The Independent UK
Business
Henry Saker-Clark

Novo Nordisk shares soar as sales of Wegovy weight loss pill smash forecasts

Pharmaceutical firm Novo Nordisk is poised to surpass its trading forecasts, buoyed by surging demand for its new Wegovy weight loss pill.

Shares in the Copenhagen-based company saw a significant uplift in early trading on Wednesday following the announcement.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.